NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Bio Blast Pharma Ltd said its lead experimental drug showed signs of being effective in treating patients with a rare muscle wasting disorder, besides also hitting the main goals of safety and tolerability. The company said the experimental drug, Cabaletta, hit multiple efficacy endpoints during a mid-stage trial on patients…

news

Gw Pharmaceuticals Plc results from Sativex Phase 3 Cancer Pain Trials. Consistent with previously reported phase 3 trial, Sativex did not meet primary endpoint in these trials. GW and Otsuka have submitted a request to meet with FDA to discuss clinical relevance of U.S. Data and potential paths forward. Pre-Specified…

news

Amgen Inc and Cytokinetics Inc said on Tuesday their experimental drug for chronic heart failure showed significant improvement in cardiac function in the second part of a mid-stage study. The 448 patients in the trial were given an oral formulation of the drug omecamtiv mecarbil for 20 weeks and observed…

news

Horizon Pharma plc, a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs today announced that it has extended the expiration of its exchange offer to acquire all of the outstanding shares of common stock of Depomed,…

news

Merck & Co's approved Keytruda lung cancer treatment provided superior overall survival to chemotherapy in a late-stage study of patients with advanced disease whose tumors produce a protein called PD-L1 associated with increased risk of the disease. The U.S. drugmaker on Monday said patients taking the approved 2 milligram dosage…

news

Lupin has launched Calcium Acetate capsules, used in treating hyperphosphatemia in end stage renal failure, in the US after getting approval from United States Food and Drug Administration (USFDA). Lupin Pharmaceuticals Inc, a subsidiary of the company, has launched Calcium Acetate capsules having received final approval from the American health…

news

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, and BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company, announced that the US Food and Drug Administration (FDA) has approved Belbuca (buprenorphine) buccal film for use in patients with chronic pain severe enough to require daily, around-the-clock, long-term opioid treatment…

news

A first-in-class drug from Amgen based on a tumour-killing virus was given a green light by European regulators on Friday, paving the way for its approval within a couple of months. The decision is a further milestone for a technology that has long fascinated scientists but has previously proved difficult…

news

Drug major Lupin today said it has appointed Fabrice Egros as President, Asia Pacific and Japan. Egros, based in Tokyo, will be responsible for the company's growth and development across key markets such as Japan, Australia, the Philippines, South East Asia and new markets in rest of the ASEAN region.…

news

The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc's Strensiq, a treatment for a rare kind of metabolic disorder. Strensiq is designed to treat perinatal, infantile and juvenile-onset hypophosphatasia, a genetic and potentially fatal disorder that affects multiple systems of the body, which could lead to severe…